Thompson Siegel & Walmsley LLC Increases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Thompson Siegel & Walmsley LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 37.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,003,041 shares of the company's stock after buying an additional 274,756 shares during the quarter. Henry Schein comprises approximately 1.1% of Thompson Siegel & Walmsley LLC's portfolio, making the stock its 24th biggest position. Thompson Siegel & Walmsley LLC owned 0.80% of Henry Schein worth $73,122,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cromwell Holdings LLC raised its stake in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after buying an additional 170 shares during the last quarter. Simplify Asset Management Inc. raised its position in shares of Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company's stock worth $237,000 after purchasing an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company's stock worth $364,000 after purchasing an additional 176 shares in the last quarter. Studio Investment Management LLC grew its position in Henry Schein by 4.7% during the 2nd quarter. Studio Investment Management LLC now owns 4,502 shares of the company's stock valued at $289,000 after purchasing an additional 204 shares during the last quarter. Finally, Mather Group LLC. increased its stake in Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company's stock valued at $96,000 after purchasing an additional 216 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have commented on HSIC shares. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Evercore ISI lifted their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. Robert W. Baird lowered their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. Finally, Barrington Research restated an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and an average price target of $78.89.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $0.18 on Thursday, reaching $73.91. The company's stock had a trading volume of 1,148,326 shares, compared to its average volume of 1,385,406. The company has a 50-day simple moving average of $70.68 and a 200 day simple moving average of $69.69. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $9.21 billion, a P/E ratio of 30.42, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.32 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Buying and Selling

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.